Sionna Therapeutics, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 |
|---|---|---|---|
| Income Statement | |||
| Operating income | -$89.0 | -$70.6 | — |
| Net income | -$75.3 | -$61.7 | — |
| Cash Flow Statement | |||
| Free cash flow | -$66.7 | -$52.8 | — |
Shares outstanding 45.2M · Free float 28.1%
Annual filing data through FY ended December 31, 2025; float as of October 6, 2026.